Evidence map›Paper›PMID 41142457›Full record

ArticleRegenerative therapy2025

Primed human pluripotent stem cell-derived blastocyst-like cell aggregates with partial lineage specification.

Kaori Mutsuda-Zapater, Xiaopeng Wen, Satoshi Imamura, Shiho Terada, Kyoko Sawada, Kei Saito, Ken-Ichiro Kamei

Abstract read
In one paragraph

Article in Regenerative therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kaori Mutsuda-ZapaterIntegrated Cell-Material Sciences, Kyoto University Institute of Advanced Science, Yoshida-Ushinomiya-cho, Sakyo-ku, Kyoto 606-8601, Japan.
Xiaopeng WenIntegrated Cell-Material Sciences, Kyoto University Institute of Advanced Science, Yoshida-Ushinomiya-cho, Sakyo-ku, Kyoto 606-8601, Japan.
Satoshi ImamuraProgram of Biology, Division of Science, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Shiho TeradaIntegrated Cell-Material Sciences, Kyoto University Institute of Advanced Science, Yoshida-Ushinomiya-cho, Sakyo-ku, Kyoto 606-8601, Japan.
Kyoko SawadaIntegrated Cell-Material Sciences, Kyoto University Institute of Advanced Science, Yoshida-Ushinomiya-cho, Sakyo-ku, Kyoto 606-8601, Japan.
Kei SaitoIntegrated Cell-Material Sciences, Kyoto University Institute of Advanced Science, Yoshida-Ushinomiya-cho, Sakyo-ku, Kyoto 606-8601, Japan.
Ken-Ichiro KameiIntegrated Cell-Material Sciences, Kyoto University Institute of Advanced Science, Yoshida-Ushinomiya-cho, Sakyo-ku, Kyoto 606-8601, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Human blastoids, blastocyst-like structures assembled Methods: We developed a method to generate human blastocyst-like cell aggregates directly from primed hPSCs using a thermoresponsive hydrogel. Generated blastocyst-like cell aggregates were evaluated for morphological features, lineage marker expression via immunocytochemistry, transcriptional profiles using single-cell RNA sequencing, and functional capacity through Results: Primed hPSC-derived blastocyst-like cell aggregates recapitulated key morphological features of human blastocysts, including cyst formation and spatial expression of epiblast, trophectoderm, and primitive endoderm markers. Single-cell RNA sequencing revealed that a subset of cells showed transcriptional profiles resembling epiblast-, trophectoderm-, and primitive endoderm-like cells although a substantial proportion remained undifferentiated. Functionally, blastocyst-like cell aggregates demonstrated Conclusions: This work introduces a more accessible platform for generating human blastocyst-like cell aggregates from primed hPSCs, broadening their utility for investigating early development events. Insights gained from blastocyst-like cell aggregates have the potential to advance the modelling of early-onset diseases, drive innovations in regenerative therapies, and contribute to the development of assisted reproductive technologies.

Indexed as

BlastocystBlastocyst-like cell aggregateBlastoidEmbryo modelHuman pluripotent stem cellsHydrogelPrimed pluripotency

Identifiers

PMID41142457
PMCPMC12550238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.